Oman approves India’s Covaxin for travel without quarantine

<p>
<strong>Oman today added Covaxin, developed by the Indian Council of Medical Research (ICMR) in partnership with Bharat Biotech International Limited (BBIL), to the approved list of Covid-19 vaccines for travel to the country.<br />
</strong><br />
In a notification issued on Wednesday, Oman's Civil Aviation Authority said that all the passengers from India who have received two doses of Covaxin at least 14 days before the estimated arrival date will now be able to travel to Muscat without the requirement of quarantine.<br />
<br />
All other Covid-19 related requirements and conditions, such as pre-arrival RT-PCR test shall be applicable for such passengers.<br />
<br />
This notification will significantly ease travel to Oman for Indian nationals who have taken Covaxin. Passengers who have taken AstraZeneca/Covishield are already permitted to travel to Oman without quarantine.<br />
<br />
The Indian embassy in Oman has also conveyed its gratitude to the government of the Sultanate of Oman for their cooperation and support.</p>
<p>
<strong>Also Read: <a href="https://www.indianarrative.com/health-news/bharat-biotech-s-covaxin-approved-for-children-in-to-years-age-group-120964.html">Bharat Biotech’s Covaxin approved for children in 2 to 18 years age group</a></strong></p>
<p>
<strong><br />
</strong></p>